AI Article Synopsis

  • The study aimed to examine how metformin and alogliptin affect body composition in Japanese individuals with type 2 diabetes over 12 weeks.
  • Participants (84 in total) received either alogliptin or metformin, with body composition and weight-related factors as main outcomes.
  • Results indicated that alogliptin led to weight gain while metformin showed no significant impact; higher baseline BMI was linked to weight loss with metformin and weight gain with alogliptin.

Article Abstract

Aims/introduction: The aim of the present study was to investigate the effects of metformin and a dipeptidyl peptidase-4 inhibitor, alogliptin, on body composition in a 12-week randomized add-on trial in Japanese participants with type 2 diabetes.

Materials And Methods: A total of 84 participants with poorly controlled type 2 diabetes undergoing antidiabetic therapy were randomly assigned to receive alogliptin (25 mg, once daily) or metformin (1,000 mg, twice daily) for 12 weeks. The primary efficacy end-point was body composition. The secondary end-points included factors associated with decreased bodyweight.

Results: Compared with the baseline values, alogliptin significantly increased bodyweight (66.5 ± 19.2 to 67.6 ± 19.3 kg), body mass index (BMI; 25.4 ± 6.1 to 25.8 ± 6.3 kg/m ) and fat mass (20.3 ± 12.8 to 21.8 ± 14.5 kg), whereas metformin had no significant effect on body composition. Alogliptin was inferior to metformin in reducing bodyweight (0.84 ± 1.57 vs -0.35 ± 1.53 kg, P = 0.002), BMI (0.34 ± 0.69 to -0.15 ± 0.56 kg/m , P = 0.002) and fat mass (1.49 ± 5.06 vs -0.04 ± 1.81 kg, P = 0.042). BMI at baseline was associated with changes in bodyweight negatively in the metformin group and positively in the alogliptin group.

Conclusions: Metformin and alogliptin exert opposite effects on bodyweight in type 2 diabetes patients who are overweight. The higher the BMI, the more metformin reduces bodyweight and alogliptin increases weight.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497598PMC
http://dx.doi.org/10.1111/jdi.12920DOI Listing

Publication Analysis

Top Keywords

body composition
16
effects metformin
8
alogliptin
8
metformin alogliptin
8
alogliptin body
8
type 2 diabetes
8
fat mass
8
metformin
7
body
5
bodyweight
5

Similar Publications

Background: End-stage renal disease (ESRD) patients frequently experience protein-energy wasting (PEW), which increases their morbidity and mortality rates.

Objective: This study explores the effects of nutritional status and pulmonary function on the short- and long-term mortality of ESRD patients undergoing hemodialysis.

Materials And Methods: 67 consecutive ESRD patients on maintenance hemodialysis were included in the study.

View Article and Find Full Text PDF

Correlation between body composition variables, plantar pressure and pain level.

Acta Bioeng Biomech

September 2024

PhD, Associate Professor and Researcher Sports Science Department, Vice-president of Faculty of Human Social Sciences University of Beira Interior, Covilhã, Portugal; Research Center in Sports, Health and Human Development, Covilhã, Portugal.

From a current perspective, it is understood that body posture is influenced by individual asymmetries, cultural context, habitual body patterns, etiological factors and psychosocial factors allocated to the individual. Clarifying the musculoskeletal cause that originated the postural alteration is considered the clinical challenge in the treatment of pain or discomfort. Recent studies have shown the influence of changes in body weight on the distribution of plantar pressure and foot pain, emphasizing the importance of understanding these relationships.

View Article and Find Full Text PDF

This study tested the effects of propylene glycol (PG) on the fatty acid composition of Akkaraman lambs in three different anatomical depot locations (ADLs). Twenty-four lambs were assigned to a randomized complete block design comprising three groups of 8 animals as follows: Con, 1.5%, body weight (BW) (PG1.

View Article and Find Full Text PDF

Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans.

Physiol Rev

January 2025

Metabolism, Obesity, and Nutrition Lab, School of Health, Concordia University, Montréal, Québec, Canada.

Adult males and females have markedly different body composition, energy expenditure, and have different degrees of risk for metabolic diseases. A major aspect of metabolic regulation involves the appropriate storage and disposal of glucose and fatty acids. The use of sophisticated calorimetry, tracer, and imaging techniques have provided insight into the complex metabolism of these substrates showing that the regulation of these processes varies tremendously throughout the day, from the overnight fasting condition to meal ingestion, to the effects of physical activity.

View Article and Find Full Text PDF

Background: Chest computed tomography (CT) is a valuable tool for diagnosing and predicting the severity of coronavirus disease 2019 (COVID-19) and assessing extrapulmonary organs. Reduced muscle mass and visceral fat accumulation are important features of a body composition phenotype in which obesity and muscle loss coexist, but their relationship with COVID-19 outcomes remains unclear. In this study, we aimed to investigate the association between the erector spinae muscle (ESM) to epicardial adipose tissue (EAT) ratio (ESM/EAT) on chest CT and disease severity in patients with COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!